---
title: "RT: Zhou Xiaofeng has reduced his holdings by 0.1262%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/260865684.md"
description: "RT announced that senior management personnel Mr. Zhou Xiaofeng reduced his holdings by 260,000 shares through centralized bidding from August 6, 2025, to October 10, 2025, accounting for 0.1262% of the company's total share capital, with a transaction price range of 17.34 to 23.5 yuan/share, cashing out 5.4525 million yuan; after the reduction, he holds 1.2775 million shares, accounting for 0.6201%. This reduction plan has been completed"
datetime: "2025-10-13T09:15:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/260865684.md)
  - [en](https://longbridge.com/en/news/260865684.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/260865684.md)
generator: "portal-rs"
---

# RT: Zhou Xiaofeng has reduced his holdings by 0.1262%

RT announced that senior management personnel Mr. Zhou Xiaofeng reduced his holdings by 260,000 shares through centralized bidding from August 6, 2025, to October 10, 2025, accounting for 0.1262% of the company's total share capital, with a transaction price range of 17.34 to 23.5 yuan/share, cashing out 5.4525 million yuan; after the reduction, he holds 1.2775 million shares, accounting for 0.6201%, and this reduction plan has been completed

### Related Stocks

- [603036.CN](https://longbridge.com/en/quote/603036.CN.md)

## Related News & Research

- [Cloud snail-mail service Docmail enters third day stuck in the outbox](https://longbridge.com/en/news/298033318.md)
- [05:26 ETArtprice by Artmarket presenta un liber mundi, dixit Gemini: "Diálogo entre un pensador y la IA"](https://longbridge.com/en/news/297761809.md)
- [02:18 ETZPMC Holds Naming Ceremony for First Two 38,000 DWT Multipurpose Heavy-Lift Vessels for Chipolbrok](https://longbridge.com/en/news/297740243.md)
- [Canonical shuttering some of its legacy chat channels](https://longbridge.com/en/news/298053823.md)
- [Egetis says new Emcitate clinical data from Triac Trial II, ReTRIACt to be presented at September congresses](https://longbridge.com/en/news/297996002.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**